Published in Cancer J on December 06, 2010
Epilogue. J Natl Cancer Inst Monogr (2012) 0.75
Effect of dutasteride on the risk of prostate cancer. N Engl J Med (2010) 12.78
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Are racial and ethnic minorities less willing to participate in health research? PLoS Med (2005) 7.88
Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2010) 4.76
American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol (2007) 4.45
Survival of blacks and whites after a cancer diagnosis. JAMA (2002) 4.27
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2005) 4.10
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2007) 3.91
Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer. J Thorac Oncol (2013) 3.67
Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2009) 3.25
Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat (2002) 3.19
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat (2008) 2.97
Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2011) 2.76
The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer (2010) 2.63
Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base. Eur Urol (2012) 2.61
American society of clinical oncology policy statement: disparities in cancer care. J Clin Oncol (2009) 2.12
Low-dose spiral CT screening and evaluation of the solitary pulmonary nodule. Oncology (Williston Park) (2014) 2.06
Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin (2015) 1.97
Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin (2014) 1.95
The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol (2008) 1.93
Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin (2013) 1.75
Palliative care and the quality of life. J Clin Oncol (2011) 1.75
Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst (2002) 1.44
American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol (2004) 1.44
High prevalence of triple-negative tumors in an urban cancer center. Cancer (2008) 1.43
Effects of untreated syphilis in the negro male, 1932 to 1972: a closure comes to the Tuskegee study, 2004. Urology (2005) 1.42
Economic burden of cancer survivorship among adults in the United States. J Clin Oncol (2013) 1.41
Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer (2010) 1.38
Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer (2008) 1.36
The Medical Expenditure Panel Survey (MEPS) experiences with cancer survivorship supplement. J Cancer Surviv (2012) 1.31
Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum (2004) 1.31
Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program. Cancer (2010) 1.28
Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis. Am J Clin Oncol (2008) 1.28
Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists. J Cancer Surviv (2013) 1.18
Medical costs and productivity losses of cancer survivors--United States, 2008-2011. MMWR Morb Mortal Wkly Rep (2014) 1.18
Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States. Cancer Epidemiol Biomarkers Prev (2012) 1.14
Follow-up of colorectal cancer patients after resection with curative intent-the GILDA trial. Surg Oncol (2004) 1.14
Racial disparities in colorectal cancer. Curr Probl Cancer (2007) 1.11
Morbidity and mortality of gastrectomy for cancer in Department of Veterans Affairs Medical Centers. Surgery (2002) 1.11
Colorectal carcinoma in black and white race. Cancer Metastasis Rev (2003) 1.07
Prostate cancer: current evidence weighs against population screening. CA Cancer J Clin (2009) 1.05
Prostate cancer in black and white Americans. Cancer Metastasis Rev (2003) 1.05
Cholecystectomy in patients with prior ventriculoperitoneal shunts. Am J Surg (2011) 1.05
Insurance status and survival disparities among nonelderly rectal cancer patients in the National Cancer Data Base. Cancer (2010) 1.04
Appendectomy for appendicitis in patients with schizophrenia. Am J Surg (2007) 1.03
Association of insurance status and age with cervical cancer stage at diagnosis: National Cancer Database, 2000-2007. Am J Public Health (2012) 1.02
Risk factors for adverse outcomes following surgery for small bowel obstruction. Ann Surg (2006) 1.02
Risk factors for adverse outcomes after the surgical treatment of appendicitis in adults. Ann Surg (2003) 1.02
Myeloma and race: a review of the literature. Cancer Metastasis Rev (2003) 1.00
The globalization of tobacco use: 21 challenges for the 21st century. CA Cancer J Clin (2010) 1.00
Disparities in medical care among commercially insured patients with newly diagnosed breast cancer: opportunities for intervention. Cancer (2010) 0.99
Introducing the 2010 American Cancer Society prostate cancer screening guideline. CA Cancer J Clin (2010) 0.99
Risk-based mammography screening: an effort to maximize the benefits and minimize the harms. Ann Intern Med (2012) 0.98
Costs of follow-up after potentially curative treatment for extremity soft-tissue sarcoma. Int J Oncol (2004) 0.97
Is race really a negative prognostic factor for cancer? J Natl Cancer Inst (2009) 0.97
Hemipelvectomy for severe decubitus ulcers in patients with previous spinal cord injury. Am J Surg (2003) 0.97
Surveillance of patients with breast cancer after curative-intent primary treatment: current practice patterns. J Oncol Pract (2011) 0.97
The study of accrual to clinical trials: can we learn from studying who enters our studies? J Clin Oncol (2004) 0.97
Racial disparities in lung cancer. Curr Probl Cancer (2007) 0.96
Examining racial differences in diffuse large B-cell lymphoma presentation and survival. Leuk Lymphoma (2013) 0.95
NIH consensus development statement on hydroxyurea treatment for sickle cell disease. NIH Consens State Sci Statements (2008) 0.95
Comparison of angioplasty and surgery for neonatal aortic coarctation. Ann Thorac Surg (2005) 0.95
Access to preventive health care for cancer survivors. Am J Prev Med (2013) 0.94
A black-white comparison of the quality of stage-specific colon cancer treatment. Cancer (2010) 0.93
Fontan operation: a comparison of lateral tunnel with extracardiac conduit. Ann Thorac Surg (2007) 0.92
Appendectomy for appendicitis in patients with a prior ventriculoperitoneal shunt. J Surg Res (2007) 0.91
Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer. Cancer (2009) 0.90
Avoidable cancer deaths globally. CA Cancer J Clin (2011) 0.90
Depression increases risk of incident myocardial infarction among Veterans Administration patients with rheumatoid arthritis. Gen Hosp Psychiatry (2009) 0.89
Some perspective on black-white cancer statistics. CA Cancer J Clin (2002) 0.89
Taking action to ease suffering: advancing cancer pain control as a health care priority. CA Cancer J Clin (2009) 0.89
Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages. Am J Cancer Res (2013) 0.89
Follow-up for patients with colorectal cancer after curative-intent primary treatment. J Clin Oncol (2004) 0.89
Long-term management of patients after potentially curative treatment of extremity soft tissue sarcoma: practice patterns of members of the Society of Surgical Oncology. Surg Oncol (2005) 0.88
Racial differences in the incidence and outcomes for patients with hematological malignancies. Curr Probl Cancer (2007) 0.88
Patterns of disease and surgical treatment among United States veterans more than 50 years of age with ulcerative colitis. Am J Surg (2003) 0.88
Oncologists' and primary care physicians' awareness of late and long-term effects of chemotherapy: implications for care of the growing population of survivors. J Oncol Pract (2013) 0.88
A systematic review of large-scale surveys of cancer survivors conducted in North America, 2000-2011. J Cancer Surviv (2012) 0.87
Annual patient time costs associated with medical care among cancer survivors in the United States. Med Care (2014) 0.86
The receipt and utilization of effective clinical smoking cessation services in subgroups of the insured and uninsured populations in the USA. J Behav Health Serv Res (2012) 0.86
Physicians' beliefs about breast cancer surveillance testing are consistent with test overuse. Med Care (2013) 0.86
Patient surveillance after curative-intent surgery for rectal cancer. Int J Oncol (2005) 0.85
Extremity soft tissue sarcoma patient follow-up: tumor grade and size affect surveillance strategies after potentially curative surgery. Int J Oncol (2003) 0.85
Informed consent for prostate-specific antigen-based screening. Urology (2003) 0.84
Evaluation of patients with clinically suspected melanoma recurrence: current practice patterns of plastic surgeons. Int J Oncol (2002) 0.84
A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessment. Int J Radiat Oncol Biol Phys (2012) 0.84
Receipt of locoregional therapy among young women with breast cancer. Breast Cancer Res Treat (2012) 0.84
Geographical variation in surveillance strategies after curative-intent surgery for upper aerodigestive tract cancer. Ann Surg Oncol (2006) 0.84
The postoperative surveillance of patients with colon cancer and rectal cancer. Am J Surg (2006) 0.83
Breast cancer in patients with schizophrenia. Am J Surg (2013) 0.82
Determinants of the combined use of external beam radiotherapy and brachytherapy for low-risk, clinically localized prostate cancer. Cancer (2013) 0.82
Health care policy and cancer survivorship. Cancer (2013) 0.82
Lung cancer and race: equal treatment yields equal outcome among equal patients, but there is no equal treatment. J Clin Oncol (2005) 0.82
Aminoglycosides for intra-abdominal infection: equal to the challenge? Surg Infect (Larchmt) (2002) 0.82
CDC Grand Rounds: the future of cancer screening. MMWR Morb Mortal Wkly Rep (2015) 0.82
Patient surveillance after treatment for soft-tissue sarcoma. Int J Oncol (2011) 0.81
How surgeon age affects surveillance strategies for extremity soft tissue sarcoma patients after potentially curative treatment. J Surg Res (2002) 0.81
Peak window of suicides occurs within the first month of diagnosis: implications for clinical oncology. Psychooncology (2011) 0.81